3D Bioprinting Solutions, based in Russia, has announced that they have followed through on their promise and have announced that they have produced the world’s first 3D printed transplantable organ, a thyroid gland which will be used on a mouse.

3D bioprinting startup BioBots has just surpassed the $300k mark on their FundersClub campaign.

Vancouver-based Aspect Biosystems , founded in 2013, announced the closing of an oversubscribed seed round funded by the local Vancouver Angel community.  Like Organovo, Aspect hopes to print human organs.

Kyushu University was awareded a patent for “Method for production of three-dimensional structure of cells.”

Cyfuse Biomedical and Cyberdyne signed a $12 million deal to develop and market the Regenova 3D tissue printing system.

Tissues with extracellular matrix, embedded vasculature, and multiple cell types and embedded with growth factors for long duration have been reported to be 3-D bioprinted.

Israeli company, Nano dimension has proposed use of stem cells in 3-D bioprinters which will be groundbreaking to medical world. The whole project is in partnership with stem cell research company Accellta.

Researchers at UTSA are planning to start printing organs by next year. Dr. Guda expresses how regenerating bones and muscle tissues would no longer be a dream in world of medical bioprinting, cutting off the donor's list criteria on large scale.

8 month old suffering Craniosynostosis, a rare congenital skull deformity was treated using 3D printing technology to produce exact replica model of his skull. Surgery was conducted on May 21 at Shanghai Children’s Medical Center and saw the power of 3D Printing as a future perspective.

Researchers at Wake Forest University, North Carolina, say they have created a 3D printer that can actually replace real tissues, organs and bones in human body. Although the research has been performed at mice only, the success was a miracle without any necrosis or signs of cell death.

Leading 3D Printing companies are already using Bio-inks, when Israeli company, CollPlants has different plans. Plant-based RhCollagen is totally new to 3D Printing market, especially after it is backed up by Israel's Ministry of Economy by 1.4 million USD.

Started by Rebecca and her husband, Emmanuel, Canadian company Tactile Vision Graphics is seeking funds to develop Braille-friendly 3D printer. Rebecca, who is vision impaired, intends to develop this unique printer by themselves specifically for blind people.

With 3 days still remaining for their Kickstarter campaign, Anvil Electronic Technology has already raised 101k$ with their affordable 3D Printer, Anvil. Currently, Anvil team will be focussing to make their current 3D printer user-friendly printer as much as it can be.

Partnering with Jacob Institute, Stratasys is going to open Centre of Excellence to advance the use of medical devices. This new COE will aim to develop and test new medical devices, enrich clinical education and serve as a referral center for hospitals.

Additive Industries, established in 2012, emerged in RAPID 2016 with it's MetalFAB1 3D Printer targeting to revolutionise metal 3d printing. With capability of 10-fold metal production, the company seeks feedback from customers to find if it the hype is a cannonball or a belly flop.

Rokit, South Korean 3D printing company, received $3M from government last year as a boost and has now appeared with its Edison Invivo 3D Printer to take on Bio-printing market. Edison Invivo uses a bio ink to produce cell structures in the form of organic tissue, and compatible biomaterials include PLGA, PCL, PLLA, collagen, Alginate, Silk fibroi.

Researchers from the Cybernetics Department of the Military University of Technology in Warsaw have developed 3D Printed Artificial Hearts from Zortrax M200 3D printers, which are currently being used for research purpose solely. However, company is looking forward to use these Artificial 3D Printed Hearts as transplants in patients.

Additive Industries and its design partner VanBerlo have won Red Dot Awardfor their industrial 3D metal printing system, MetalFAB1. This printer is the company’s first integrated additive manufacturing machine for high-end metal parts, and its VanBerlo-designed exterior reflects advanced industrial technology’s aesthetics.

Aether 1 bioprinter is one of the 3D Bio-Printers that is capable of printing two bones connected by a tendon using six materials that include synthetic bone, conductive ink, stem cells and graphene oxide. When usual bio-printers may cost upto 200,000$, the Aether 1 Bio-printer costs only 9000$ and they will be rolled out soon after some donations to researchers and universities.

Cell Applications, Inc. and Cyfuse Biomedical K.K. have announced that advanced tissue-engineering services are now available in North America using a new three-dimensional (3D) bioprinting approach called the "Kenzan Method". Using Cyfuse Biomedical's Regenova® 3D Bio Printer, Cell Applications has created a pay-for-service bio-printing model that makes scaffold-free tissue available immediately to scientists in the U.S. and Canada for research use.

With launch of Jet Fusion 3D Printing Solution, the first 3D Printer by HP which is “ten times faster, half the cost”, the company had been looking for new powders for the Jet Fusion printer, for which they announced an Open Platform model calling developers for the Powder Materials. Evonik, a German specialty chemicals maker, has replied to the call and going in partnership with HP to produce new powder 3D printing materials for the HP Jet Fusion 3D printer. Other material developing company including Arkema from France and BASF from Germany had also joined the venture.

A report by Future Market Insights has stated that 3D Printing is expected to grow huge by year 2016 especially in medical and dental fields with 4.6 million 3D Printers to be sold by 2026. While 3D Printing has opened doors for every sector, these two sectors will benefit greatly. Some companies like Stratasys, 3D Systems and ExOne are having reduced sales for now but the boom of this sector will heighten their fortunes too.

Researchers from Advancing Innovations Biosciences have developed a Bio-sample collection solution using an open source Printrbot Play 3D printer for $750. Team at AI Biosciences took a low-cost Printrbot Play, modified it by replacing the extruder with a magnet based tip-comb attachment and further used that to conduct particle-based nucleic acid extractions. Then they programmed the 3D printer to move about its available axis to collect up to 12 samples simultaneously in under 13 minutes.

Making its debut at this year's TCT show in Birmingham will be Stratasys’ recently-launched J750 3D printer, reportedly the world’s only full colour, multi-material 3D printer. The J750 is designed for prototypes, as well as tooling, moulds, jigs and fixtures and its unique 3D printing capabilities enable users for the first time to combine full colour gradients with a range of materials to achieve the most realistic parts in the industry, easily and without post-processing.

University of Wollongong, Australia has rolled out a free online course on Medical Bio-Printing that will teach the participants about the basics of 3D Printing body parts such as hip implants and facial implants. The 4-week interactive course will teach the story of 3D Printing revolution, introduce participants with commonly used biomaterials, including metals, ceramics and polymers, and how bioprinting techniques, such as selective laser melting, hot-melt extrusion and inkjet printing, work. Finally, the participants can grab their own Certificate of Achievement after completing the course.

Korean Central Television (KCTV) recently revealed some footages that showed Pyongyang University of Science and Technology, North Korea, giving demonstration of their own 3D printer to reporters, with the statement that it can print bone for dental and cosmetic surgery procedures. Apart from that, KCTV showed two documents they stated were a “patent of certification” and a certification of assessment from the “intellectual products exhibition”.

The relationship between Medicine and 3D printing market is expected to rise, and cross the $3.89 billion mark by 2022. To these, achievements like the launch of 3D printed organs, which will cause a rapid decrease in the testing of new drugs, and medicine on animals, are constantly adding to the potential of 3D Printing. 3D printers can create specifically designed medicine with accurate dosage size, color and delivery modes which are patient orientated and improve patient care.

Amy Karle, from Artist in Residence at Autodesk has used CAD design and 3D Printing to create scaffolds in support of cell growth into certain forms by which 3D Printed framework for tissue generation can be made. She makes her own 3D Printed material using polyethylene (glycol) diacrylate (PEGDA) hydrogel and 3D Printing it by Ember 3D Printer.

The South Korean company, iMakr Med Platform, recently revealed their new 3D Printer called the Rokit Invivo Hybrid Bio 3D Printer, which is set to be sold at $34,000 USD and functions as the first hybrid modular bioprinter. The printer contains Invivo gel that helps constructing 3D tissue scaffolds which can be used for potential transplantation.

3D Bioprinting is being used in laboratories to produce hearts, livers, kidneys, etc. and no doubt, will be printed in reality for organ transplantation in real patients. But this on the other side, has increased the risk of black market and the ways bad guys will be utilizing these 3D Printed Organs. Since these organs will be available for normal people easily, criminals will find ways to make it not so.

Dental materials manufacturer Valplast International Corp and Arfona, a 3D Printing startup have together introduced a new 3D Printer called r.Pod Desktop 3D Printer which can print flexible metal-free partial dentures. The printer supports dual extruders for printing multicolor parts, can handle ABS, PLA, NinjaFlex and taulman3D filaments and is set for retail at $4,999.

Students at Ludwig-Maximilian University of Munich and the Technical University of Munich formed up a team called Team BiotINK and have discovered a way of 3d printing without going through scaffold formation. Using ultimaker 2+ 3d printer and biotink with streptavidin, the 3d printing can now be done without scaffolds and hence reducing the cost of 3d printing.

One roadblock to 3D printing complete, functional organs lies in our inability to ensure the engineered tissue will be well nourished with an accessible blood supply.  Presently we have seen attempts at recreating arteries and veins, but successfully ensuring blood flow deep into tissue to the level of the capillary beds has proven elusive. A group of bioengineers and clinicians have pioneered a technique allowing them to print a fibrin patch containing organized endothelial cells, the cellular linining of blood vessels. Not only did the printed patch enhance blood vessel formation, but the engineered vascular tissue actually integrated with the host's own vasculature, improving tissue perfusion of damaged tissues. This research provides a novel technique that may permit printing of larger blocks of tissue and even organs.

The Institute for Development of Advanced Applied Systems (IRNAS), located in Slovenia, operates Symbiolab, an open source-based biolab that focuses on the development of future-proof 3D biofabrication. The company developed Vitaprint, an open source platform which has now been used by IRNAS to fabricate 3D Printed Blood Vessels into a human earlobe using the freeform perfusable vessel and channel systems into bio-compatible hydrogels.

Researchers at the University of Wollongong have developed a new 3D bioprinter called the Pancreatic Islet Cell Transplantation (PICT) 3D Printer which can provide a newer treatment to patients of sever Type 1 Diabetes. The Bioprinter, developed by ARC Centre of Excellence for Electromaterials Science (ACES) and ANFF Materials, is capable of delivering insulin-producing islet cells from a protective bioink into a 3D printed scaffold that can be transplanted and prevent rejection risks.

T3D, a spin-off from National Taiwan University of Science and Technology (NTUST, unveiled their smartphone-powered 3D Printer at Inside 3D Printing Shanghai 2015. The Kickstarter campaign was set up since 2012 and it finally managed to raise $160,093 this September for their resin-based 3D Printing. The smartphone 3D printer can cure a 100 micron layer in 15 seconds; it features Bluetooth connectivity and uses a patented UV-curable resin.

A team of scientists in New Zealand are 3D Printing Tumor cells using real cells and then using them to develop new treatment plans for Breast Cancer. Dr. Elisabeth Phillips and Khoon Lim, also of the University of Otago, came up with the 3D printing idea and obtained funding to research breast cancer through bioprinted tumors. The team believes it is first of its kind in New Zealand following 3D printing of brain tumor cells in Scotland.

A team of researchers in tissue engineering, 3D biofabrication, biomaterials design and stem cell differentiation at Harvard’s Wyss Institute is working on 3D Printing a Functioning Kidney Subunit with current work to build branched vascular network unique to each organ. Using advanced 3D Bioprinting from Wyss Institute, Dr. Jennifer Lewis’s organ-on-chips are ready, using special polymer inks for creation of structures made up of human cells, complete with vasculatures and extracellular matrices.

A group of researchers from Japan’s Osaka University have developed a new bioprinting ink using a method based on hydrogelation mediated by horseradish peroxidase, an enzyme that can create cross-links between phenyl groups of an added polymer in the presence of the oxidant hydrogen peroxide. This bioprinting ink will be better substitute of Sodium Alginate as it will allow 3D Printing of more variety of scaffolds.

An international research team collaborated to 3D Print Simple Liver Model using bioprinted tissue to develop a more accurate drug toxicity testing system. The new advancement can construct vascularized tissue, which is then able to mimic drug administration in vivo in 3D bioprinted liver tissue. This new model will allow scientists to observe the in vivo effects of drug absorption without having to actually set up a real in vivo study.

A group of researchers at the University of Oxford have developed a new method of bioprinting that involves self-contained, self-supporting cells using a droplet-based 3D bioprinter. Researchers were able to successfully 3D printed human embryonic kidney (HEK) cells and ovine mesenchymal stem cells (oMSCs) at a high droplet resolution of one nL. The ability to 3D print with adult stem cells is believed to have a greater impact on regenerative medicine globally.

A team of 3D Printing experts at New York University (NYU) have started creating 3D Printed Masks for Facial Transplants Donors using accurate 3D Printing and Acrylic material. Since it is a tough decision to give up the face of deceased by family members, this 3D Printed Mask will encourage more people to agree to donate the faces of their dying family members for transplant purposes. Using Handheld Scanner to scan donor’s face, and then sending files to large 3D Printer, the final product is made using acrylic-based photopolymer.

Researchers from Imperial College London (ICL) have developed new 3D Printing Technique to create biological replicas for tissue regeneration. In collaboration with Kings College London, they experimented with 3D Printing and Cryogenics using solid Carbon Dioxide (dry ice) to quickly cool down hydrogel ink and Ultimaker 3D Printer. Once the ink softens, it forms a gel as soft as human tissue, which was then seeded with Dermal Fibroblasts with success.

Researchers at EPFL in Switzerland have developed 3D printed microstructures with a 1.0 micron lateral and 21.5-micron axial printing resolution by detailing their approach towards existing laser-based microfabrication techniques which uses two-photon photopolymerization. The research team is now working toward clinical use for their technique while developing biocompatible photopolymers and a compact delivery system.

Researchers at A*STAR’s Singapore Institute of Manufacturing Technology (SIMTech) and the Singapore Centre for 3D Printing (SC3DP) at Nanyang Technological University have developed a way to create pigmentation in 3D printed skin by using bioprinting to control the distribution of melanin-producing skin cells, on a biomimetic tissue substrate. They used three different types of skin cells and drop on demand method of bioprinting to create the pigmented skin.

Luke Massella was born with Spina Bifida, a medical condition that causes gap in spine, which required multiple surgeries to be able to walk. However, he faced bladder malfunction and kidney failure, for which Dr. Anthony Atala of Boston Children’s Hospital developed 3D Printed Bladder using Massella’s bladder tissue and modified 3D inkjet machines. The 14 hour surgery of transplantation of 3D Bioprinted Urinary Bladder was successful saving the now 27 year old Massella.

A research team at American Association of Physicists in Medicine recently published an article revealing how effective 3D Printing is for producing Organ Phantoms (models of organs to test things like proper medication dosage). Three questions were explored including the resolution of 3D Printing, materials used against scanning modality and feasibility of radioactive solutions as per 3D Printing is concerned. 50 studies conducted later concluded that 3D Printing undoubtedly has some limits, but is the fastest growing and can be definitely considered the best approach for Organ Phantoms as the new materials are unveiled.

Under a thesis by a student named Cristian Ghibaudo, 3D bioprinting was discussed regarding the better wound treatments under Onskin project based on microfibrillar cellulose, or MFC, and sustainable materials. The concept was developed in four modules: the moisturizing module (M1), the absorbent module (M2), the barrier module (M3) and the support module (M4). Using BioX 3D Printers, several wound dressing prototypes were 3D printed out of which the Flat prototype was selected concluding it had good mechanical properties and high resolution, plus it printed in only 30 minutes.

Researchers from the Polytechnic University of Catalonia (UPC) in Barcelona developed a new method of designing porous scaffolds for FDM 3D printing using a dual-extruder Sigma 3D printer from BCN3D to fabricate three sample scaffolds out of PLA, and then measuring their pore size and total porosity. They applied their model to a disc shape and defined three different variables: Distance between parallel planes; Number of base points for columns on each plane and Radius of each column.

A team from the Polymer Materials for Tissue Engineering and Transplantology Laboratory of Peter the Great St. Petersburg Polytechnic University (SPbPU) in a joint project with researchers from the Russian Academy of Sciences and Pavlov First St. Petersburg State Medical University, has developed innovative, polymeric medical materials that can be used to fix human organs that have undergone trauma. The team have created a porous, 3D material made of chitosan – a bone tissue analog – and collagen which can mimic the body tissues and prevent itself from being rejected by the immunity of human body.

A group of researchers from Tokyo Dental College set up a “One-stop 3D printing lab” at the college for the purposes of quickly and inexpensively designing and 3D printing models for oral and maxillofacial surgery. The researchers created their One-Stop 3D printing Lab by generalizing the software and hardware around its inexpensive Value3D MagiX MF-2000 desktop 3D printer from MUTOH Industries Ltd. The researchers determined, by 3D printing dental models daily, that the amount of preparation cost and modeling material can be lowered by increasing the laminating pitch.

Dr. Pardraig Strappe, a microbiologist in central Queensland along with a team of researchers at CQUniversity, is using 3D printing, human stem cells, and crocodile cartilage to develop a 3D Printed Joint Cartilage to treat arthritis and joint injuries. The process involves extracting growth factors from crocodile cartilage, removing the proteins that set off a human immune response and adding adult stem cells using CELLINK 3D bioprinter.

3D Bioprinting company Allevi, formerly known as BioBots and California-based 3D printing and space technology firm Made In Space, have partnered to develop the Allevi ZeroG – the first 3D bioprinter in space launched at the recent ISS Conference in San Francisco, and also found the first two users of the new 3D bioprinting platform in Astronauts, Mark Vendei Hei and Randy Bresnik. Allevi also developed a compatible extruder, fittingly called the ZeroG bio-extruder, that is able to be outfitted onto Made In Space’s Additive Manufacturing Facility currently on board the ISS.

Researchers from University of Colorado Boulder have developed a 3D printing technique with SLA that allows for localized control of an object’s firmness, which can potentially pave way for tissue 3D printing technique. The layer-by-layer printing method with fine-grain and programmable control over rigidity allows the researchers to mimic the complex geometry of highly structured yet pliable blood vessels. The 3D printer used by the researchers is capable of printing biomaterials as small as 10 microns, or one-tenth the width of a human hair.

Allevi, a Bioprinter Company launched in 2014 has been famous for bioprinters such as Allevi One to Allevi 6, but they are also selling the Ink Kits usable with their printers, aiming at binding customers, getting revenue and building stronger relationship with their customers. After the FRESH Kit, they have launched Coaxial Extrusion Kit, which can create perfusable microchannels with hydrogels and cast endothelial microchannels, thus extending their use in all sorts of tissue types from Cartilage, Skeletal muscle, hearts and tumors.

The Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University, Netherlands, have announced their partnership with Aspect Biosystems, a tissue engineering and 3D bioprinting company. Through this collaboration, RX1 Bioprinting Platform by Aspect will be placed inside Professor Lorenzo Moroni’s Lab at the university, which then will be used by Dr. Carlos Mota to work towards 3D Printed Kidney Tissue. There, Dr. Carlos Mota, the head of bioprinting research, will put it to good use developing 3D bioprinted kidney tissue.

3DHEALS is an organization, founded by CEO Jenny Chen, aims at building a global platform for people to learn and collaborate on healthcare 3D printing and bioprinting, and related technologies through events around the globe. The event involved local speakers like Adam Jakus, Co-founder of Dimension Inx, Steven Morris, CEO of BIOLIFE4D, Stephen Anderson from Renishaw and Alejandro Espinoza from Rush; who gave 10 minute summaries of their work for an audience of additive manufacturing professionals in Chicago.

A team from the Research Center for Nano-Biomaterials at Sichuan University worked on four groups of scaffolds, namely: PCL, PCL/PVAc, PCL/HA and PCL/PVAc/HA. By 3D Printing them on 3D Bioprinter V2.0 (manufactured by Hangzhou Regenovo Biotechnology Co., Ltd, China), they revealed that although they had almost similar porosity, the mechanical properties were different. PCL/PVAc/HA scaffold was selected the winner with more favorable characteristics during in vitro cell culture experiment and in vivo bone formation.

An international Team of Bioengineers from the Bio-Microrobotics Laboratory of the Daegu Gyeongbuk Institute of Science and Technology (DGIST) partnered with the Ajou University and Microsystems Lab of the Swiss Federal Institute of Technology Lausanne (EPFL), using the Nanoscribe Photonic Professional system to create microstructure scaffolds for the Cochlear implant. Accompanied by a high-precision 3D printed steroid reservoir with a 2D MEMS-based electrode array, the medical device- “Germany’s Nanoscribe” is meant to allow patients to hear better—and by avoiding insertion trauma, preserves what hearing ability they still possess. The implant is designed to reduce the damage of residual hearing against electrode insertion trauma.

3D Systems has received FDA 510(k) Clearance for their Biocompatible Dental Material, NextDent Denture 3D+, developed for use on the NextDent 5100 3D printing platform. According to 3D Systems, combination with the NextDent C&B MFH material, which has been designed to print the teeth of a denture, users can save up to 90% in cost and 75% in time for producing the base of denture. The new material also possesses excellent mechanical properties in accordance with ISO Denture Base Standards and the comprehensive colour palette allows dental labs are able to match the printed product to the patient’s gums.